Caribou Biosciences, Inc. (CRBU), a clinical-stage CRISPR genome-editing company, said on Thursday that it has appointed Sri Ryali as Chief Financial Officer with immediate effect.
Most recently, Ryali served as the CFO of Codexis, Inc., an enzyme engineering firm. Previously, he worked as CFO of Eiger BioPharmaceuticals, Inc.
For comments and feedback: editorial@rttnews.com